5. References
- IBM Micromedex® DRUGDEX® (electronic version). IBM Watson Health, Greenwood Village, Colorado, USA. Available at: https://www-micromedexsolutions-com.libproxy.uthscsa.edu/ (cited: June 2, 2023).
- Clinical Pharmacology [database online]. Tampa, FL: Gold Standard, Inc.; 2023. Available at: http://clinicalpharmacology-ip.com.ezproxy.lib.utexas.edu/. Accessed June 2, 2023.
- Donepezil hydrochloride transdermal patch (Adlarity®) package insert. Corium, LLC. March 2022.
- Donepezil tablets, orally disintegrating tablets (Aricept®, Aricept® ODT) Package Insert. Eisai Inc., November 2022.
- Galantamine extended-release capsules package insert. Aurobindo Pharma Limited. November 2022.
- Galantamine film coated oral tablet package insert. Aurobindo Pharma Limited. August 2021.
- Galantamine hydrobromide oral solution package insert. Hikma Pharmaceuticals USA, Inc. March 2022.
- Rivastigmine transdermal system (Exelon® Patch) package insert. Novartis, December 2020.
- Rivastigmine tartrate oral capsules package insert. Alembic Pharmaceuticals, Inc. April 2022.
- Memantine extended-release/donepezil capsules (Namzaric®) package insert. Allergan USA, Inc., January 2019.
- Battle CE, Abdul-Rahim AH, Shenkin SD, et al. Cholinesterase inhibitors for vascular dementia and other vascular cognitive impairments: a network meta-analysis. Cochrane Database Syst Rev. 2021 Feb 22;2(2):CD013306.
- Hershey LA, Coleman-Jackson R. Pharmacological management of dementia with lewy bodies. Drugs Aging. 2019;36(4):309-319.
- Kim JO, Lee SJ, Pyo JS. Effect of acetylcholinesterase inhibitors on post-stroke cognitive impairment and vascular dementia: A meta-analysis. PLoS One. 2020 Feb 7;15(2):e0227820.
- Cotter J, Muhlert N, Talwar A, et. al. Examining the effectiveness of acetylcholinesterase inhibitors and stimulant-based medications for cognitive dysfunction in multiple sclerosis: A systematic review and meta-analysis. Neuroscience & Biobehavioral Reviews. 2018;86:99-107.